Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection

Journal of the American Society of Nephrology

Volumn 23, Issue 9, 2012, Pages 1528-1537

  Kinsey, Gilbert R ^a   Huang, Liping ^a   Jaworska, Katarzyna ^a   Khutsishvili, Konstantine ^a   Becker, David A ^a   Ye, Hong ^a   Lobo, Peter I ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2A RECEPTOR; CD39 ANTIGEN; CREATININE; MESSENGER RNA; PROGRAMMED DEATH 1 RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FLOW CYTOMETRY; INNATE IMMUNITY; KIDNEY INJURY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84865964344     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012010070     Document Type: Article

References (35)

1. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A: Incidence and outcomes in acute kidney injury: A comprehensive population-based study. J Am Soc Nephrol 18: 1292-1298, 2007 (Pubitemid 46536915)
2. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
3. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D,Ordoñez JD, Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893-899, 2009
4. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009
5. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD: Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 77: 771-780, 2010
6. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, Crow MT, King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
7. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE: Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 117: 1061-1070, 2011
8. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265, 2007 (Pubitemid 46919862)
9. Ring S, Enk AH, Mahnke K: Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production. J Invest Dermatol 131: 1494-1502, 2011
10. Alam MS, Kurtz CC, Rowlett RM, Reuter BK, Wiznerowicz E, Das S, Linden J, Crowe SE, Ernst PB: CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199: 494-504, 2009
11. Romio M, Reinbeck B, Bongardt S, Hüls S, Burghoff S, Schrader J: Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am J Physiol Cell Physiol 301: C530-C539, 2011
12. Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ: CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 71: 2892-2900, 2011
13. Okusa MD, Linden J, Macdonald T, Huang L: Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 277: F404-F412, 1999 (Pubitemid 29459653)
14. Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, Chen JF, Schwarzschild MA, Fink JS, Linden J, Okusa MD: Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112: 883-891, 2003 (Pubitemid 38063746)
15. Möser GH, Schrader J, Deussen A: Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256: C799-C806, 1989
16. Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB: Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 177: 2765-2769, 2006 (Pubitemid 44277790)
17. Bedke T, Pretsch L, Karakhanova S, Enk AH, Mahnke K: Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: Involvement of programmed death-1 and IL-10. J Immunol 184: 5562-5570, 2010
18. Sitkovsky MV: T regulatory cells: Hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 30: 102-108, 2009
19. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J: Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203: 2639-2648, 2006 (Pubitemid 44833340)
20. Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD: A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259, 2008
21. Sevigny CP, Li L, Awad AS, Huang L, McDuffie M, Linden J, Lobo PI, Okusa MD: Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 178: 4240-4249, 2007 (Pubitemid 46492374)
22. Okazaki T, Honjo T: PD-1 and PD-1 ligands: From discovery to clinical application. Int Immunol 19: 813-824, 2007 (Pubitemid 47241890)
23. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H: Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol 19: 337-343, 2007 (Pubitemid 46344699)
24. Wang W, Lau R, Yu D, Zhu W, Korman A, Weber J: PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol 21: 1065-1077, 2009
25. Zhou Q, Munger ME, Highfill SL, Tolar J, Weigel BJ, Riddle M, Sharpe AH, Vallera DA, Azuma M, Levine BL, June CH, Murphy WJ, Munn DH, Blazar BR: Programdeath-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 116: 2484-2493, 2010
26. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, Fonseca SG, Van Grevenynghe J, Boulassel MR, Bruneau J, Shoukry NH, Routy JP, Douek DC, Haddad EK, Sekaly RP: Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16: 452-459, 2010
27. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ, Hoogsteden HC, Lambrecht BN: Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 36: 2472-2482, 2006 (Pubitemid 44420603)
28. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU, Barnaba V: PD-L1 negatively regulates CD4 +CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-564, 2009
29. Lai LW, Yong KC, Lien YH: Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int 81: 983-992, 2012
30. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R,Morote-Garcia JC, Colgan SP: Crucial role for ecto-59-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200: 1395-1405, 2004 (Pubitemid 39657287)
31. Glover DK, Ruiz M, Takehana K, Petruzella FD, Riou LM, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA: Pharmacological stress myocardial perfusion imaging with the potent and selective A (2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation 104: 1181-1187, 2001 (Pubitemid 32830405)
32. Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden JM, Murray TF: Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils. Am J Vet Res 68: 981-987, 2007 (Pubitemid 47408328)
33. Henderson RB, Hobbs JAR, Mathies M, Hogg N: Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102: 328-335, 2003 (Pubitemid 36759673)
34. Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S: Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 33: 2090-2097, 2003 (Pubitemid 37010025)
35. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM,Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A: Evidence based selection of housekeeping genes. PLoS ONE 2: e898, 2007